With regard to the generic pharmaceutical industry, Quebec is an attractive market. We have major plants in Montreal, specifically Pharmascience, which is the largest pharmaceutical manufacturer in Quebec. Our industry continues to invest in that province.
The problem you referred to applies more to brand-name pharmaceutical companies who have seen patents on a number of their products expire. At present, it is extremely difficult to encourage the sector by giving patent extensions, particularly because not enough products are in the pipeline.
I believe that the solution is to establish a fair intellectual property system. We will make some suggestions to improve the situation. A fair system for brand-name companies and manufacturers of generic products would be the best option and would help to increase investments.